Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged supression of plasma HIV-1 RNA in children.

A. Saitoh, Karen Hsia, Terence Fenton, Christine Powell, Cindy Christopherson, Courtney V. Fletcher, Stuart E. Starr, Stephen A. Spector. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged supression of plasma HIV-1 RNA in children.. Journal of Infectious Diseases. 2002. 185: 1409-16.

Year

2002

Journal

Journal of Infectious Diseases

T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.

W. E. Naugler, Florence H. Yong, Vincent J. Carey, Joan Dragavon, Robert W. Coombs, Lisa M. Frenkel. T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.. Journal of Infectious Diseases. 2002. 4: 448-55.

Year

2002

Journal

Journal of Infectious Diseases

Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in HIV-1 infected children.

Joseph A. Church, Coleen Cunningham, Michael Hughes, Paul Palumbo, Lynne M. Mofenson, Patricia Mastrodonato DeLora, Elaine Margaret Smith, Andrew A. Wiznia, Lynette Purdue, Elizabeth Hawkins, Prakash Sista. Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in HIV-1 infected children.. Pediatric Infectious Disease Journal. 2002. 21: 653-9.

Year

2002

Journal

Pediatric Infectious Disease Journal

Study

P1005

Pediatric HIV-1 infection: Advances and Remaining Challenges.

John L. Sullivan, Katherine Ruiz Luzuriaga. Pediatric HIV-1 infection: Advances and Remaining Challenges.. AIDS Clinical Review. 2002. 22-7.

Year

2002

Journal

AIDS Clinical Review

Pharmacokinetic Characteristics of Ritonavir, Stavudine, Zidovudine, and Lamivudine in HIV-infected Children

Courtney V. Fletcher, Ram Yogev, Sharon Appelbaum Nachman, Andrew A. Wiznia, Stephen Ira Pelton, Kenneth McIntosh, Kenneth Stanley. Pharmacokinetic Characteristics of Ritonavir, Stavudine, Zidovudine, and Lamivudine in HIV-infected Children. Pharmacotherapy. 2002. 24: 453-9.

Year

2002

Journal

Pharmacotherapy

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir in pretreated children infected with human immunodeficiency virus type 1.

Paul Krogstad, Sophia S. Lee, George M. Johnson, Kenneth Stanley, James McNamara, John ( Jack ) Moye, Brooks Jackson, Rosaura M. Aguayo, Arry Dieudonne, Margaret Khoury, Hermann A. Mendez, Sharon Appelbaum Nachman, Andrew A. Wiznia. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir in pretreated children infected with human immunodeficiency virus type 1.. Clinical Infectious Diseases. 2002. 34: 991-1001.

Year

2002

Journal

Clinical Infectious Diseases

Infrequent detection of HIV-1 specifiec, but not CMV specific, CD8+ T cell responses in young HIV-1 infected infants.

Z. A. Scott, Ellen Gould Chadwick, Lynn Gibson, Margaret McManus, Ram Yogev, Paul Palumbo, John L. Sullivan, Paula Britto, Hannah Gay, Katherine Luzuriaga. Infrequent detection of HIV-1 specifiec, but not CMV specific, CD8+ T cell responses in young HIV-1 infected infants.. Journal of Immunology. 2002. 167: 7134-40.

Year

2002

Journal

Journal of Immunology

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche

Keith D. Chirgwin, Richard Hafner, Catherine Leport, Jack S. Remington, Janet Andersen, Elizabeth M. Bosler, Clemente Roque, Natasa Rajicic, Vincent J. McAuliffe, Philippe Morlat, Dushyantha T. Jayaweera, Jean-Louis Vilde, Benjamin J. Luft. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche. Clinical Infectious Diseases. 2002. 34: 1243-50. PMID: 11941551

Year

2002

Journal

Clinical Infectious Diseases

Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir and saquinavir after simultaneous and staggered oral administration

Jian-Feng Lu, Terrence F. Blaschke, Charles Flexner, Susan L Rosenkranz, Lewis Sheiner. Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir and saquinavir after simultaneous and staggered oral administration. Drug Metabolism and Disposition. 2002. 30: 1455-61.

Year

2002

Journal

Drug Metabolism and Disposition

A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy

Judith A. Aberg, Richard W. Price, Dorie M. Heeren, Barry Bredt. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. Journal of Infectious Diseases. 2002. 185: 1179-82.

Year

2002

Journal

Journal of Infectious Diseases